Aging can cause many changes to the body, including obesity and a loss of lean mass. Now, a group of University of Florida Health researchers has discovered that an existing drug reduces body fat and ...
Scientists have identified a new anti-ageing drug class that works by acting on a key gut bacteria process, an advance that ...
New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates ...
Immune checkpoint inhibitors (ICIs) emerged in the US about 15 years ago as an exciting class of cancer treatments that have achieved complete and durable remissions for thousands of people with ...
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...
About 1 million people in the U.S. live with multiple sclerosis, a chronic autoimmune disease that inflames the nervous ...
In separate treatment trials, one for de novo coronary lesions and the other for in-stent restenosis, a sirolimus-eluting ...
News-Medical.Net on MSN
Sirolimus-eluting balloon emerges as a safe and effective option for coronary in-stent restenosis
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...
The DCB is meant to address long-term stent-related complications and avoid adding yet another metal layer in ISR.
Results from the first randomized clinical trial in the United States to compare a sirolimus-eluting balloon (DEB) to a ...
Orchestra BioMed (Nasdaq:OBIO) today announced the first patient enrollments in a study of its Virtue Sirolimus AngioInfusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback